Josiah Allen is a PharmD student at the University of Minnesota. Prior to pharmacy school, Josiah worked for 10 years in clinical research and medical affairs in pharmacogenomics at Mayo Clinic, Assurex Health, and OneOme. He also serves as Founder and Principal Consultant for Medigenics Consulting LLC, a personalized medicine consulting company that provides commercial laboratories and other stakeholders with market assessment, scientific product development, and medical affairs services. Josiah's research focus is on clinical implementation of pharmacogenomics, with a focus in mental health. His current work involves development of a psychometrically-validated pharmacogenomic knowledge assessment for use in clinical and research settings.
Katelyn J. France is a PharmD student at the University of Minnesota. She completed a B.S. in Biochemistry and a B.A. in German Studies at the University of Minnesota Duluth. She is the founder and CEO of Scientists Making Your Life Easier (SMYLE) LLC, a medical technologies and mentorship-focused company that produces accessible life-saving medical equipment while also providing opportunities for networking and assistance for students pursuing STEM projects and careers. She is currently working with Dr. Jacob Brown of the University of Minnesota - Duluth School of Pharmacy on a pharmacogenomics project assessing sertraline concentrations in children stratified by their CYP2C19 genotype.
Yingbo is a graduate student in Dr.Stephanie Huang's lab. He received his BS in Pharmaceutical Science at China Pharmaceutical University and MS at the University of the Pacific, major in Drug Targeting and Delivery. Yingbo is interested in developing in vitro and in vivo translational models for cancer research, specifically in bridging the molecular features of cancers and the drug response together. Currently, his research is focusing on analyzing sex differences on genomic & transcriptomic levels of both malignant and healthy tissue, and exploring the pharmacogenomic relevance of these differences.
I come from the prairielands of Minnesota where I got an AA and an AS from the local community college before doing my BS in Biochemistry at Northern Michigan University. I took two years off to farm with my Dad before joining the Ph.D. program in Cancer Biology at the University of Chicago and joining Stephanie's lab. While still a UChicago student, I followed Stephanie when she moved her lab to UMN in the Fall of 2017. My current research is focused on developing algorithms that use data from cancer cell line montherapy screens to predict the clinical effectiveness of combination therapies.
Josh Mentzer is a member of the lab of Stephanie Huang. He is in the PhD program in Experimental and Clinical Pharmacology. He has an undergraduate education in Genetics from Iowa State University, only two hours west of Cedar Rapids, where he grew up. He is exploring all of the current projects in the lab to determine the focus of his thesis.
I received my undergraduate degree at Peking University Health Science Center, China. My major during undergraduate was Pharmaceutical Sciences. Now I am a PharmD student at the U and also a research volunteer in Dr. Huang’s lab. I am currently working on finding the relationship between lncRNAs and the response to certain anticancer drugs.
Jay Wen is a PharmD graduate of the University of Minnesota and PhD candidate in Experimental and Clinical Pharmacology. His current research interests include using pharmacogenomics and pharmacometrics approaches to optimize medication therapy and exploring health system registries to enhance patient’s treatment experience. One of the projects is the continuation of a study of Genetic Basis of Gout in a Hmong Population at Risk, an adjunct study of pharmacokinetic, pharmacogenetic and pharmacodynamic data collected by the Genetics Of HyperUricemia Therapy in Hmong (GOUT-H) study to explore the genetic basis of gout in a under-served and under-studied population, the Hmong population at risk during.
His second project focuses on the determination of known genetic variations within very important pharmacogenes (VIPs) in the Hmong population which brings local, state-wide and regional relevance to the nationally supported NIH “All of Us” program.
Lusi Zhang is a PhD candidate in the University of Minnesota Experimental and Clinical Pharmacology program. She graduated with a PharmD from the University of Minnesota. Her research focuses include psychiatric genetics, pharmacogenomics, and psychopharmacology.